Immune Therapeutics, Inc. Business Finance Contracts & Agreements
47 Contracts & Agreements
- Assignment Agreements (2 contracts)
- Exchange Agreements (2)
- Loan Agreements (2)
- Note Agreements (29)
- Purchase Agreements (2)
- Release Agreements (1)
- Shareholders Agreements (1)
- Stock Agreements (3)
- Term Sheets (1)
- Warrant Agreements (4)
- First Amendment to Promissory Note between Immune Therapeutics, Inc. and Ira Gaines dated November 4, 2022 (Filed With SEC on April 10, 2023)
- Convertible Promissory Note in the Principal Amount of $200,000, dated July 19, 2022, between Immune Therapeutics, Inc. and Kevin Phelps (Filed With SEC on July 22, 2022)
- Convertible Promissory Note in the Principal Amount of $100,000, dated July 19, 2022, between Immune Therapeutics, Inc. and Kevin Phelps (Filed With SEC on July 22, 2022)
- Convertible Promissory Note in the Principal Amount of $100,000, dated July 19, 2022, between Immune Therapeutics, Inc. and Kevin Phelps (Filed With SEC on July 22, 2022)
- Term Sheet (Filed With SEC on July 7, 2022)
- Promissory Note dated March 11, 2021 between Immune Therapeutics, Inc., and Robert J. Dailey (Filed With SEC on March 18, 2022)
- Promissory Note dated March 11, 2021 between Immune Therapeutics, Inc., and Global Reverb Corporation (Filed With SEC on March 18, 2022)
- Note Exchange Agreement dated March 31, 2021 between Immune Therapeutics, Inc. and Global Reverb Corporation and Robert J. Dailey (Filed With SEC on March 18, 2022)
- Note Assignment dated November 10, 2020 between Iliad Research and Trading, L.P. and Global Reverb Corporation (Filed With SEC on March 18, 2022)
- Note Purchase Agreement dated November 10, 2020 entered into by Iliad Research and Trading, L.P. and Global Reverb Corporation (Filed With SEC on March 18, 2022)
- Promissory Note dated March 11, 2021 between Immune Therapeutics, Inc., and Robert J. Dailey (Filed With SEC on May 24, 2021)
- Promissory Note dated March 11, 2021 between Immune Therapeutics, Inc., and Global Reverb Corporation (Filed With SEC on May 24, 2021)
- Note Exchange Agreement dated March 31, 2021 between Immune Therapeutics, Inc. and Global Reverb Corporation and Robert J. Dailey (Filed With SEC on May 24, 2021)
- Note Assignment dated November 10, 2020 between Iliad Research and Trading, L.P. and Global Reverb Corporation (Filed With SEC on May 24, 2021)
- Note Purchase Agreement dated November 10, 2020 entered into by Iliad Research and Trading, L.P. and Global Reverb Corporation (Filed With SEC on May 24, 2021)
- Promissory Note dated February 27, 2019 to Phoenix Group in the principal amount of $231,478.39 (Filed With SEC on April 15, 2021)
- Amendment to the Articles of Incorporation filed March 12, 2020 approving an increase in authorized shares of common stock from 500,000,000 to 750,000,000 (Filed With SEC on August 14, 2020)
- Amendment to the Articles of Incorporation filed February 5, 2020 approving a reverse split of issued and outstanding shares of common stock by 1,000 to 1 (Filed With SEC on August 14, 2020)
- Securities Purchase Agreement dated as of June 15, 2020 with Geneva Roth Remark Holdings, Inc, together with Exhibit A Convertible Promissory Note in the principal amount of... (Filed With SEC on June 29, 2020)
- Securities Purchase Agreement dated as of May 4, 2020 with Geneva Roth Remark Holdings, Inc, together with Exhibit A Convertible Promissory Note in the principal amount of $53,000 (Filed With SEC on June 29, 2020)
- Convertible Promissory Note dated March 30, 2020 to Redstart Holdings Corp. in the principal amount of $53,000 (Filed With SEC on May 14, 2020)
- Promissory Note dated February 27, 2019 to Phoenix Group in the principal amount of $231,478.39 (Filed With SEC on May 14, 2020)
- Mutual Release and Non-Disparagement Agreement effective April 30, 2020 (Filed With SEC on May 5, 2020)
- Promissory Note dated February 27, 2019 to Phoenix Group in the principal amount of $231,478.39 (Filed With SEC on May 20, 2019)
- Letter to Shareholders (Filed With SEC on May 15, 2019)
- Promissory Note dated February 27, 2019 to Phoenix Group in the principal amount of $231,478.39 (Filed With SEC on April 16, 2019)
- Stock Agreement (Filed With SEC on June 11, 2018)
- Loan agreement and promissory note with Rogoff Family Trust, dated February 13, 2018, for $50,000 (Filed With SEC on May 15, 2018)
- Loan agreement and promissory note with Joel Yanowitz, dated January 9, 2018, for $50,000 (Filed With SEC on May 15, 2018)
- Iliad Research and Trading (i) promissory note and (ii) warrant dated October 25, 2017 (Filed With SEC on April 2, 2018)
- Securities Purchase Agreement dated October 25, 2017 with Iliad Research and Trading, L.P (Filed With SEC on April 2, 2018)
- Securities Purchase Agreement and Warrant dated May 1, 2017 with Ira Gaines (Filed With SEC on April 2, 2018)
- Promissory Note dated April 5, 2017 to Robert J. Dailey in the principal amount of $150,000 (Filed With SEC on April 2, 2018)
- Promissory Note dated February 6, 2017 issued to Phoenix Fund Management, LLC (Filed With SEC on April 2, 2018)
- Intellectual Property Assignment Agreement with Cytocom, Inc. dated September 4, 2015 (Filed With SEC on April 2, 2018)
- Promissory Note Settlement Agreement, dated September 26, 2014, between Immune Therapeutics, Inc. and Robert Dailey for notes equaling $400,000 (Filed With SEC on April 2, 2018)
- Promissory Note Settlement Agreement, dated September 26, 2014, between Immune Therapeutics, Inc. and Robert Dailey for notes equaling $399,000 (Filed With SEC on April 2, 2018)
- Securities Purchase Agreement and Note with Iliad Research & Trading LP dated October 20, 2017 (Filed With SEC on November 14, 2017)
- ADDENDUMTO COMMONSTOCK PURCHASE WARRANT DOCUMENTW-04122016 (Filed With SEC on December 1, 2016)
- Securities Purchase Agreement and related agreements with JMJ Financial dated April 12, 2016 (filed as Exhibit 10.1 to our Current Report 8-K on April 18, 2016, and incorporated... (Filed With SEC on April 2, 2018)
